By Sahil Pandey March 10 (Reuters) - Medical device maker Medtronic said on Tuesday it would buy U.S.-based Scientia Vascular ...

Medtronic announced today that it has entered into a definitive agreement to acquire Scientia Vascular for $550 million.

GlobalData analyst Dr Andrew S Thompson’s states Medtronic could significantly grow Scientia’s micro guidewire franchise if they can replicate its US success on the international stage.

Medtronic today announced its entry into a definitive agreement to acquire Scientia Vascular, a company with critical, innovative technology across the neurovascular portfolio. The acquisition is ...

Medtronic acquire neurovascular device company Scientia Vascular for $550 million, expanding its portfolio with guidewires and catheters.

Sleep Number's new CEO is planning to make the bed manufacturer profitable with a smaller product lineup. Also, Medtronic has ...

Medtronic (NYSE:MDT) continues to lead in medical technology, making significant contributions to the S&P 500 Chart ...

MINNEAPOLIS – Medtronic, Inc. today announced that it has entered into an exclusive distribution agreement with Miami Instruments, LLC – a company focused on the design of innovative surgical ...

In early March 2026, Medtronic reported stronger-than-expected Q3 2026 results with 6% year-over-year organic revenue growth and affirmed a US$0.71 quarterly dividend per share, extending its 48-year ...

Medtronic ended its fiscal year with nominal sales growth and a steep profit drop, but analysts who cover the medical device company are confident a windfall is ahead, thanks to a strong lineup of ...

Two patients who were injured by Medtronic's controversial Infuse bone graft product will receive a combined $8.45 million in settlements with the University of California Los Angeles, where a doctor ...

Medtronic (NYSE:MDT) has been found liable for violating U.S. antitrust laws in the advanced bipolar devices market. A ...